Yao et al. found that the activation of FXR with GW4064 alleviates liver injury caused by lipopolysaccharide (LPS) by disturbing the release of inflammatory cytokines from macrophages in the non-alcoholic fatty liver disease (NAFLD) mice model. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.